Skip to main content


Health

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
210 of 1193




Newsletter Sign Up

Daily Readings

Reading 1, Sirach 2:1-11
My child, if you aspire to serve the Lord, prepare yourself for ... Read More

Psalm, Psalms 37:3-4, 18-19, 27-28, 39-40
Put your trust in Yahweh and do right, make your home in the ... Read More

Gospel, Mark 9:30-37
After leaving that place they made their way through Galilee; ... Read More

Saint of the Day

May 21 Saint of the Day

St. Eugene de Mazenod
May 21: Eugene de Mazenod was born on August 1, 1782, at Aix-en-Provence ... Read More